Society guideline links: Anaphylaxis

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Perioperative anaphylaxis" and "Society guideline links: Drug allergy and hypersensitivity".)

International

●World Allergy Organization (WAO): Anaphylaxis guidance (2020)

●International Consensus (ICON): Anaphylaxis (2014)

Canada

●Choosing Wisely Canada: Don't use antihistamines as first-line treatment in anaphylaxis (2021)

●Canadian Paediatric Society (CPS): Position statement for emergency treatment of anaphylaxis in infants and children (2011, reaffirmed 2018)

United States

●American Academy of Pediatrics (AAP): Clinical report on epinephrine for first-aid management of anaphylaxis (2017, reaffirmed 2024)

●AAP: Red Book – Treatment of anaphylactic reactions (2024)

●Joint Task Force on Practice Parameters (JTFPP): Anaphylaxis – A practice parameter, update (2023)

•JTFPP: Anaphylaxis – A practice parameter update, systematic review, and grading of recommendations, assessment, development, and evaluation (GRADE) analysis (2020)

●Wilderness Medical Society (WMS): Clinical practice guidelines on anaphylaxis (2022)

●An expert panel consensus on guiding principles for the recognition, diagnosis, and management of infants with anaphylaxis (2019)

●European Academy of Allergy and Clinical Immunology (EAACI) and American Academy of Allergy, Asthma, and Immunology (AAAAI): PRACTALL document on precision medicine in allergic disease – Food allergy, drug allergy, and anaphylaxis (2017)

Europe

●European Academy of Allergy and Clinical Immunology (EAACI): Guidelines on anaphylaxis, update (2021)

●EAACI: Position paper on diagnosis and management of drug-induced anaphylaxis in children (2019)

●EAACI and American Academy of Allergy, Asthma, and Immunology (AAAAI): PRACTALL document on precision medicine in allergic disease – Food allergy, drug allergy, and anaphylaxis (2017)

●EAACI: Consensus statement on occupational anaphylaxis (2015)

●EAACI: Position statement on pathophysiological mechanisms of exercise-induced anaphylaxis (2015)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Quality standard on anaphylaxis (2016, updated 2024)

●Resuscitation Council UK (RCUK): Algorithm for anaesthetists for the emergency treatment of peri-operative anaphylaxis (2024)

●RCUK: Guidelines for healthcare providers for the emergency treatment of anaphylaxis (2021)

●NICE: Clinical guideline on anaphylaxis – Assessment and referral after emergency treatment (2011, updated 2020)

●Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Anaphylaxis (2011)

●British Society for Allergy and Clinical Immunology (BSACI): Guidelines for the investigation of suspected anaphylaxis during general anaesthesia (2009)

Australia–New Zealand

●Australasian Society of Clinical Immunology and Allergy (ASCIA): Guidelines for acute management of anaphylaxis (2023)

●ASCIA: Guidelines on adrenaline (epinephrine) injector prescription (2023)

●ASCIA: Guidelines for acute management of anaphylaxis in pregnancy (2020)

●Choosing Wisely Australia: Don't use antihistamines to treat anaphylaxis – Prompt administration of adrenaline (epinephrine) is the only treatment for anaphylaxis (2017)

Japan

●[In Japanese] Japanese Society of Allergology (JSA): Anaphylaxis guidelines (2022)